Healthy Extracts Inc. (HYEX) Focuses on Growth in 2021, Reaching a Potential Market of 200 Million People
Company reports positive clinical results from HERHEART(TM) and Fuel4Thought(TM), produced by subsidiaries BergaMet North America and Ultimate Brain Nutrients Purchase agreement with Xymogen(R) for BergaMet North America’s Citrus Bergamot SuperFruit(TM) expected to generate significant revenue and distribution opportunities nationwide The global market for botanical and plant-derived drugs was valued at $29.4 billion in 2017 and is expected to reach $39.6 billion by 2022 Healthy Extracts is nearly debt-free with minimal overhead costs Through a growing portfolio of wholly owned subsidiaries, Healthy Extracts (OTCQB: HYEX) (formerly Grey Cloak Tech) is engaged in proprietary research and development of natural plant-based formulations, sales,…